# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Neurofibromatosis

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 63 results.
The Neurofibromatosis-associated Tumor Biobank
Status: Not yet recruiting
Last Changed: Dec 02, 2017
First Received: Dec 02, 2017
Disease(s): Neurofibromatoses
Photodynamic Therapy for Benign Dermal Neurofibromas
Status: Recruiting
Last Changed: Aug 29, 2018
First Received: Apr 05, 2016
Disease(s): NEUROFIBROMATOSIS 1
Intervention(s): PDT Treatment
Locations: The Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Effect of Lamotrigine on Cognition in NF1
Status: Recruiting
Last Changed: Jul 26, 2018
First Received: Oct 03, 2014
Disease(s): Neurofibromatosis Type 1
Intervention(s): Lamotrigine, Placebo
Locations: University Hospital Leuven, Leuven, Belgium
Erasmus Medical Center, Rotterdam, South Holland, Netherlands
Hospital Sant Joan de Deu, Barcelona, Spain
Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1 (NF1) on Clinical Treatment Trials
Status: Recruiting
Last Changed: Oct 31, 2018
First Received: May 22, 2018
Disease(s): Neurofibromatosis 1, Neurofibroma, Plexiform
Intervention(s): Medication Event Monitoring System (MEMS)
Locations: Johns Hopkins University, Baltimore, Maryland, United States
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Boston Children s Hospital, Boston, Massachusetts, United States
Childrens Hospital, Philadelphia, Philadelphia, Pennsylvania, United States
A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)
Status: Recruiting
Last Changed: Oct 15, 2018
First Received: Sep 17, 2018
Disease(s): Neurofibromatosis 1 and 2 (NF1 and NF2)
Intervention(s): hand-held dynamometer
Locations: New York School of Medicine, New York, New York, United States
Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed by Surgery
Status: Recruiting
Last Changed: Mar 19, 2018
First Received: Apr 03, 2015
Disease(s): Neurofibromatosis Type 1, Plexiform Neurofibroma
Intervention(s): Laboratory Biomarker Analysis, Pharmacological Study, Quality-of-Life Assessment, Selumetinib
Locations: National Cancer Institute Pediatric Oncology Branch, Bethesda, Maryland, United States
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (PNs)
Status: Recruiting
Last Changed: Feb 11, 2019
First Received: Sep 09, 2015
Disease(s): Neurofibromatosis 1, Plexiform Neurofibromas
Locations: Children's National Medical Center, Washington, District of Columbia, United States
University of Chicago, Chicago, Illinois, United States
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain
Status: Recruiting
Last Changed: Jan 28, 2019
First Received: Jun 15, 2015
Disease(s): Neurofibromatosis Type 1, Plexiform Neurofibromas
Intervention(s): Acceptance and Commitment Therapy (ACT)
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Non-invasive Stimulation in Neurofibromatosis Type 1
Status: Recruiting
Last Changed: May 02, 2018
First Received: Oct 16, 2017
Disease(s): Neurofibromatosis 1
Intervention(s): Transcranial direct current stimulation
Locations: University of Manchester, Manchester, Greater Manchester, United Kingdom
Neurofibromatosis (NF) Registry Portal
Status: Recruiting
Last Changed: Feb 04, 2019
First Received: Jun 25, 2013
Disease(s): Neurofibromatosis 1, Neurofibromatosis 2, Schwannomatosis
Locations: Children's Tumor Fundation, New York, New York, United States